Anti-human KIR2DL2 monoclonal antibody, lirilumab biosimilar (BMS-986015, IPH2102)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1120-100ug

  • Size

    100 ug

  • Price

    $350

1
This monoclonal antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
target KIR2DL2
alias CD158b, CD158B1, NKAT-6, NKAT6, p58.2
gene id Uniprote ID: P43627
host species Human
reactivity Human
iso type IgG4
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml, solubilize at RT for 30 minutes with occasional gentle tapping. It is recommended that 0.1% HSA be added as a carrier protein for long-term storage.
applications Flow Cytometry
dilution Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.
note Other commonly used names in publications refering to this antibody: BMS-986015, IPH2102

Images

Flow cytometry analysis of 1 ug/mL anti-KIR2DL2 (lirilumab biosimilar) mAb on Expi293 cells transfected with Human KIR2DL2 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).


PRODUCT

  • SKU

    DMS1120-100ug

  • Size

    100 ug

  • Price

    $350

1